FDA Inspection
OSRX Inc.OSRX Inc. – FDA Inspection, Nov 14, 2025
Record Details
This FDA Inspection record concerns OSRX Inc., with an inspection on November 14, 2025, issued by the Seattle District Office, covering human drugs.
View Company Profile
ID · d2021fd6-4cc1-44ea-a35b-57a6016a0abe
Inspection Facts
- Inspection number
- 1283268
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.165(e)Test methods
- 21 CFR 211.192Written record of investigation incomplete
- 21 CFR 211.68(b)Computer control of master formula records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of OSRX Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| October 25, 2024 | OAI | Seattle District Office | Drug Quality Assurance |
| September 23, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 25, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for OSRX Inc.
- FDA Inspection 1246254 - 2024-10-25
- FDA Inspection 1154392 - 2021-09-23
- FDA Inspection 1087576 - 2019-04-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.